A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

J Clin Psychopharmacol

Department of Cognitive Neuroscience, Donders Institute for Brain Cognition and Behavior, Radboud University Nijmegen Medical Center and Karakter Child and Adolescent Psychiatry, University Center Nijmegen, Nijmegen, the Netherlands Department of Psychiatry University Medical Center Groningen University of Groningen Groningen, the Netherlands Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Karakter Child and Adolescent Psychiatry, University Center Nijmegen, Nijmegen, the Netherlands Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Karakter Child and Adolescent Psychiatry, University Center Nijmegen, Nijmegen, the Netherlands Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands Department of Clinical Child and Adolescent Studies, Leiden Institute for Brain and Cognition, Faculty of Social Sciences, University of Leiden, Leiden, the Netherlands Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center and Karakter Child and Adolescent Psychiatry, University Center Nijmegen, Nijmegen, the Netherlands Karakter Child and Adolescent Psychiatry University Center Nijmegen and Department of Psychiatry Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands Karakter Child and Adolescent Psychiatry, University Center Nijmegen and Department of Psychiatry, Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.

Published: December 2013

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e31829c764fDOI Listing

Publication Analysis

Top Keywords

randomized double-blind
4
double-blind comparison
4
comparison atomoxetine
4
atomoxetine placebo
4
placebo response
4
response inhibition
4
inhibition interference
4
interference control
4
control children
4
children adolescents
4

Similar Publications

Background: Postoperative delirium (POD) is the most common neurological adverse event among elderly patients undergoing surgery. POD is associated with an increased risk for postoperative complications, long-term cognitive decline, an increase in morbidity and mortality as well as extended hospital stays. Delirium prevention and treatment options are currently limited.

View Article and Find Full Text PDF

Objective: The objective of this study is to evaluate the efficacy and safety of jaktinib hydrochloride tablets (jaktinib), a Janus kinase inhibitor, in patients with active radiographic axial spondyloarthritis (r-axSpA).

Methods: Adults with active r-axSpA who met modified New York criteria and had an inadequate response to non-steroidal anti-inflammatory drugs were randomised 1:1:1 to receive jaktinib 75 mg two times per day, 100 mg two times per day, or placebo. The primary and key secondary endpoints were Assessment of SpondyloArthritis international Society 20 (ASAS 20) and ASAS 40 responses, respectively, at week 16.

View Article and Find Full Text PDF

To assess and compare two techniques of low-level laser application-transgingival (TLLLT) and intrasulcular (ILLLT)-used in photobiomodulation as an adjunct to basic periodontal therapy (BPT) in patients with periodontitis. A randomized, split-mouth, double-blind clinical trial was conducted, selecting three diseased periodontal sites from different quadrants in each patient. These sites were assigned to one of three treatment groups: SRP (control), SRP + TLLLT (test 1), and SRP + ILLLT (test 2).

View Article and Find Full Text PDF

Objective: This study investigated the effects of a single dose injection of mesenchymal stem cells (MSCs) under ultrasound guidance for knee osteoarthritis (KOA).

Design: The study included 30 subjects in the intervention group, who received the MSC injection and 27 in the control group who received triamcinolone. Various outcome measures, including pain levels, range of motion (ROM), and MRI parameters, were evaluated before the intervention and at different time points after treatment.

View Article and Find Full Text PDF

Background: Intracerebral hemorrhage (ICH) is the most severe and disabling stroke, accounting for up to 50% of the cases in low-to-middle-income countries. High rates of cognitive decline and dementia follow acute ICH, due to the common underlying vasculopathy of cerebral small vessel disease (CSVD). The international clinical trial, TRIDENT (Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial), aims to determine the effectiveness of the fixed low-dose Triple Pill combination of blood pressure-lowering agents (telmisartan 20 mg, indapamide 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!